Logo image of LMNX

DEF DAILY TARG 2X L LMND ETF (LMNX) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:LMNX - US88636W7671 - ETF

32.77 USD
-5.06 (-13.38%)
Last: 12/26/2025, 8:00:00 PM
32.47 USD
-0.3 (-0.92%)
After Hours: 12/26/2025, 8:00:00 PM

LMNX Key Statistics, Chart & Performance

Key Statistics
Market Cap1.55B
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares47.31M
Float26.61M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)03-01 2022-03-01/amc
IPO2000-03-30
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


LMNX short term performance overview.The bars show the price performance of LMNX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

LMNX long term performance overview.The bars show the price performance of LMNX in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of LMNX is 32.77 USD. In the past month the price decreased by -11.68%.

DEF DAILY TARG 2X L LMND ETF / LMNX Daily stock chart

LMNX Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.93 218.19B
DHR DANAHER CORP 29.87 162.69B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 185.88 56.48B
A AGILENT TECHNOLOGIES INC 24.8 39.23B
IQV IQVIA HOLDINGS INC 19.51 38.64B
MTD METTLER-TOLEDO INTERNATIONAL 33.94 29.01B
WAT WATERS CORP 30.4 22.98B
ILMN ILLUMINA INC 30.95 20.62B
WST WEST PHARMACEUTICAL SERVICES 38.8 19.73B
MEDP MEDPACE HOLDINGS INC 39.69 15.99B
TEM TEMPUS AI INC N/A 11.15B
RVTY REVVITY INC 20.2 10.97B

Related stock screener links

DEF DAILY TARG 2X L LMND ETF / LMNX FAQ

What does LMNX do?

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company is headquartered in Austin, Texas and currently employs 1,325 full-time employees. The company went IPO on 2000-03-30. The firm's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The firm has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The firm primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.


What is the current price of LMNX stock?

The current stock price of LMNX is 32.77 USD. The price decreased by -13.38% in the last trading session.


What is the ChartMill rating of DEF DAILY TARG 2X L LMND ETF stock?

LMNX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


LMNX Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to LMNX.


Chartmill TA Rating
Chartmill Setup Rating